tirzepatide updates today Mission Family Medicine launches in-clinic program Update I received today. :

Important notice: Compounded NAD+ is not FDA-approved and is not regulated with the same standards as FDA-approved medications

By Thursday, the FDA will likely decide whether a key GLP-1 weight loss drug ingredient is still in shortage

Healthcare providers typically prescribe this contrave weight loss medication for adults with a body mass index of 30 or higher, or a BMI of 27 or higher with weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol

Avoid hot showers (use lukewarm water), limit exfoliation to once per week, and wear sunscreen dailyUV exposure worsens dryness and accelerates skin barrier damage